Actipulse Neuroscience

Bringing non-invasive brain stimulation from the hospital to the home

Operating in healthcare based in Cambridge, MA, USA; Mexico City, CDMX, Mexico, Actipulse Neuroscience operates.

Profile

Non-invasive brain stimulation is a widely-utilized, FDA cleared treatment used for patients diagnosed with depression, but is limited to a hospital setting due to the cost of the device, and complexity of treatment application.

Our proprietary brain stimulation device allows patients to be treated directly from their home, with the same efficacy, and at a lower cost of treatment.

Currently in FDA pivotal phase for Major Depressive Disorder, and Pilot phase for Alzheimer's and Parkinson diseases.

Within the healthcare space, the company focuses on its core offering rather than a broad product line.

Its base of operations is Cambridge, MA, USA; Mexico City, CDMX, Mexico.

The company is listed at the Winter 2022 stage of development.

Recorded headcount: 38 employees.

Website: www.actipulseneuroscience.com